Command Palette

Search for a command to run...

REMUS
662.1(-3.26%)
1W: -4.87%

Remus Pharmaceuticals Key Ratios

Cash Conversion Cycle

Latest:62.2 days

Return on Equity

Latest:29.9%

Return on Capital Employed

Latest:32.8%

Dupont Analysis

Analysis Summary

MetricMar 2024
ROE29.91%
PAT margin10.14%
Asset Turnover0.83x
Leverage2.95x

Efficiency Ratios

Analysis Summary

MetricMar 2024
Inventory Days73.7
Receivable Days196.6
Payable Days208.1
Cash Conversion Cycle62.2

Return Ratios

Analysis Summary

MetricMar 2024
ROE29.91%
ROCE32.84%
ROA10.13%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.

Explore
Watchlists